SCHEMBL20161193

SCHEMBL20161193

Cc1c(C)c(-c2ccccc2)c(-c2ccc(-n3c4ccc(-c5ccccc5)cc4c4cccnc43)cc2)c(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc2)c1-c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
TSHR P16473 1/20 0.42
CYP2C19 P33261 1/20 0.42
DHODH Q02127 1/20 0.36
RXRA P19793 1/20 0.36
PDE10A Q9Y233 1/20 0.35
PTGER4 P35408 2/20 0.35
NPY5R Q15761 1/20 0.34
FEN1 P39748 1/20 0.33
PIK3CA P42336 2/20 0.33
MTOR P42345 2/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CB P42338 1/20 0.33
PIK3CG P48736 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17124089 0.89 ALDH1A1 (0.49) ALDH1A1TSHRCYP2C19PDE10APTGER4
SCHEMBL20161001 0.86 ALDH1A1 (0.46) ALDH1A1TSHRCYP2C19DHODHRXRA
SCHEMBL17124141 0.85 ALDH1A1 (0.50) ALDH1A1TSHRCYP2C19PDE10APTGER4
SCHEMBL17124091 0.84 ALDH1A1 (0.47) ALDH1A1TSHRCYP2C19PDE10APTGER4
SCHEMBL20160987 0.84 KDM4E (0.44) TSHRRXRAPTGER4NPY5RKMT2A
SCHEMBL23039521 0.83 ALDH1A1 (0.42) ALDH1A1TSHRCYP2C19PDE10APTGER4
SCHEMBL17124111 0.83 ALDH1A1 (0.47) ALDH1A1TSHRCYP2C19PDE10AFEN1
SCHEMBL17124080 0.83 ALDH1A1 (0.47) ALDH1A1TSHRCYP2C19PDE10AFEN1
SCHEMBL23626743 0.83 ALDH1A1 (0.44) ALDH1A1TSHRCYP2C19RXRAPDE10A
SCHEMBL18958692 0.83 ALDH1A1 (0.46) ALDH1A1TSHRCYP2C19RXRAPDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230354701-A1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP MERCK PATENT GMBH (DE) 2023-11-02 US disclosed
US-20230354701-A1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP MERCK PATENT GMBH (DE) 2023-11-02 US disclosed
EP-4271163-A2 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP Merck Patent GmbH (DE) 2023-11-01 EP disclosed
US-11711976-B2 Compounds with an acceptor and a donor group MERCK PATENT GMBH (DE) 2023-07-25 US disclosed
US-11711976-B2 Compounds with an acceptor and a donor group MERCK PATENT GMBH (DE) 2023-07-25 US disclosed
US-20200203624-A1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP MERCK PATENT GMBH (DE) 2020-06-25 US disclosed
WO-2018087346-A1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP MERCK PATENT GMBH (DE) 2018-05-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11711976-B2 Compounds with an acceptor and a donor group NQO1, ICMT, NUDT1 ALDH1A1 242/4885TSHR 4702/4885CYP2C19 303/4885
US-20200203624-A1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP NQO1, ICMT, NUDT1 ALDH1A1 242/4885TSHR 4702/4885CYP2C19 303/4885
US-20230354701-A1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP NQO1, ICMT, NUDT1 ALDH1A1 242/4885TSHR 4702/4885CYP2C19 303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.